|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 39/39591 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/2818 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/94 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3496753 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17838513.4 |
| Date of filing the European patent application | 2017-07-17 | |
| (97) | Date of publication of the European application | 2019-06-19 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2017/093141 |
| Date | 2017-07-17 |
| (87) | Number | WO 2018/028383 |
| Date | 2018-02-15 |
| (30) | Number | Date | Country code |
| PCT/CN2016/094094 | 2016-08-09 | WO |
| (72) |
CAO, Wei , CN
LI, Junfeng , CN
LIU, Xiaolin , CN
|
| (73) |
Innovent Biologics (Suzhou) Co., Ltd. ,
168 Dongping Street
Suzhou Industrial Park, Suzhou, Jiangsu 215123,
CN
|
| (54) | PD-1 ANTIBODY FORMULATION |
| PD-1 ANTIBODY FORMULATION |